Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study

被引:9
|
作者
Crous-Bou, Marta [1 ,2 ,3 ]
Porta, Miquel [1 ,2 ,3 ]
Morales, Eva [1 ]
Lopez, Tomas [1 ,3 ]
Carrato, Alfredo [4 ]
Puigdomenech, Elisa [1 ,2 ,3 ]
Real, Francisco X. [1 ,5 ,6 ]
机构
[1] Univ Autonoma Barcelona, Clin & Mol Epidemiol Canc Unit, IMIM, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Fac Med, Barcelona 08003, Spain
[3] CIBERESP, Barcelona, Spain
[4] Univ Miguel Hernandez, Hosp Univ Elche, Alacant, Spain
[5] Ctr Nacl Invest Oncol, Madrid, Spain
[6] Univ Pompeu Fabra, Barcelona, Spain
关键词
Medical conditions; Diabetes mellitus; Pancreatitis; Peptic ulcer; Pancreatic ductal adenocarcinoma; Pancreatic neoplasms; Etiology; K-ras oncogene; RISK-FACTORS; LIFE-STYLE; CODON; 12; CANCER; HISTORY; INFLAMMATION; ASSOCIATION; P53; EPIDEMIOLOGY; METAANALYSIS;
D O I
10.1007/s10552-008-9267-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In pancreatic ductal adenocarcinoma (PDA) evidence on the etiopathogenic role of past medical conditions in the occurrence and persistence of K-ras mutations is scant. Incident cases of PDA were interviewed face-to-face about past medical history and other factors. Logistic regression was used to compare PDA cases (n = 120) with wild-type and mutated K-ras tumors (case-case study). Patients with wild-type K-ras tumors were more likely to have a prior diagnosis of pancreatitis (Odds ratio [OR] = 6.11, p = 0.041). Diabetes mellitus (DM) was non-significantly more common among cases with a K-ras wild-type tumor, and the OR for DM of > 6 years of duration was 4.54 (p = 0.39). Patients with wild-type K-ras were significantly more likely to have had a surgically treated peptic ulcer (OR = 9.03, p = 0.027). The probability of having a K-ras wild-type tumor increased with the number of medical conditions (p for trend = 0.012); the corresponding OR for two or more medical conditions was 4.46 (95% CI: 1.37-14.50). Results raise the hypothesis that pancreatitis and possibly peptic ulcer might influence pancreatic carcinogenesis through pathways independent of K-ras mutation, perhaps related to growth factors or mediators of the inflammatory response. Large unselected studies should be conducted to refute or replicate our findings.
引用
收藏
页码:591 / 599
页数:9
相关论文
共 50 条
  • [1] Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study
    Marta Crous-Bou
    Miquel Porta
    Eva Morales
    Tomàs López
    Alfredo Carrato
    Elisa Puigdomènech
    Francisco X. Real
    Cancer Causes & Control, 2009, 20
  • [2] Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma
    Crous-bou, M.
    Porta, M.
    Morales, E.
    Lopez', T.
    Real, F. X.
    EJC SUPPLEMENTS, 2008, 6 (09): : 194 - 194
  • [3] DETECTION OF K-RAS MUTATIONS IN THE STOOL OF PATIENTS WITH PANCREATIC ADENOCARCINOMA AND PANCREATIC DUCTAL HYPERPLASIA
    CALDAS, C
    HAHN, SA
    HRUBAN, RH
    REDSTON, MS
    YEO, CJ
    KERN, SE
    CANCER RESEARCH, 1994, 54 (13) : 3568 - 3573
  • [4] Lifetime History of Alcohol Consumption and K-ras Mutations in Pancreatic Ductal Adenocarcinoma
    Crous-Bou, Marta
    Porta, Miquel
    Lopez, Tomas
    Jariod, Manel
    Malats, Nuria
    Morales, Eva
    Guarner, Luisa
    Rifa, Juli
    Carrato, Alfredo
    Real, Francisco X.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2009, 50 (05) : 421 - 430
  • [5] K-RAS MUTATIONS IN PANCREATIC DUCTAL PROLIFERATIVE LESIONS
    KLIMSTRA, DS
    LONGNECKER, DS
    AMERICAN JOURNAL OF PATHOLOGY, 1994, 145 (06): : 1547 - 1548
  • [6] K-RAS MUTATIONS IN PANCREATIC DUCTAL PROLIFERATIVE LESIONS - REPLY
    HRUBAN, RH
    DIGIUSEPPE, JA
    OFFERHAUS, GJA
    AMERICAN JOURNAL OF PATHOLOGY, 1994, 145 (06): : 1548 - 1550
  • [7] CYP1B1 Polymorphisms and K-ras Mutations in Patients with Pancreatic Ductal Adenocarcinoma
    Marta Crous-Bou
    Immaculata De Vivo
    Miquel Porta
    José A. Pumarega
    Tomàs López
    Joan Alguacil
    Eva Morales
    Núria Malats
    Juli Rifà
    David J. Hunter
    Francisco X. Real
    Digestive Diseases and Sciences, 2008, 53 : 1417 - 1421
  • [8] CYP1B1 polymorphisms and K-ras mutations in patients with pancreatic ductal adenocarcinoma
    Crous-Bou, Marta
    De Vivo, Immaculata
    Porta, Miquel
    Pumarega, Jose A.
    Lopez, Tomas
    Alguacil, Joan
    Morales, Eva
    Malats, Nuria
    Rifa, Juli
    Hunter, David J.
    Real, Francisco X.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (05) : 1417 - 1421
  • [9] MICROSATELLITE INSTABILITY AND K-RAS MUTATIONS ASSOCIATED WITH PANCREATIC ADENOCARCINOMA AND PANCREATITIS
    BRENTNALL, TA
    CHEN, R
    LEE, JG
    KIMMEY, MB
    BRONNER, MP
    HAGGITT, RC
    KOWDLEY, KV
    HECKER, LM
    BYRD, DR
    CANCER RESEARCH, 1995, 55 (19) : 4264 - 4267
  • [10] K-ras mutations in pancreatic cancer
    Grady, M
    Gaut, A
    Liu, JR
    Zhang, YP
    Zhang, H
    Weydert, C
    Domann, F
    Oberley, L
    Cullen, J
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S440 - S440